{"title":"植物中抗坏血酸的生物合成:复兴。","authors":"N. Smirnoff, P. L. Conklin, F. Loewus","doi":"10.1146/ANNUREV.ARPLANT.52.1.437","DOIUrl":null,"url":null,"abstract":"The structure of the familiar antioxidant L-ascorbic acid (vitamin C) was described in 1933 yet remarkably, its biosynthesis in plants remained elusive until only recently. It became clear from radioisotopic labeling studies in the 1950s that plant ascorbic acid biosynthesis does not proceed in toto via a route similar to that in mammals. The description in 1996 of an Arabidopsis thaliana mutant deficient in ascorbic acid prompted renewed research effort in this area, and subsequently in 1998 a new pathway was discovered that is backed by strong biochemical and molecular genetic evidence. This pathway proceeds through the intermediates GDP-D-mannose, L-galactose, and L-galactono-1,4-lactone. Much research has focused on the properties of the terminal enzyme responsible for conversion of the aldonolactone to ascorbate, and on related enzymes in both mammals and fungi. Two of the plant biosynthetic genes have been studied at the molecular level and additional ascorbate-deficient A. thaliana mutants may hold the key to other proteins involved in plant ascorbate metabolism. An analysis of the biosynthesis of ascorbate and its analogues in algae and fungi as well as the study of alternative proposed pathways should broaden our understanding of ascorbate metabolism in plants. With a biosynthetic pathway in hand, research on areas such as the control of ascorbate biosynthesis and the physiological roles of ascorbate should progress rapidly.","PeriodicalId":80493,"journal":{"name":"Annual review of plant physiology and plant molecular biology","volume":"11 1","pages":"437-467"},"PeriodicalIF":0.0000,"publicationDate":"2001-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1146/ANNUREV.ARPLANT.52.1.437","citationCount":"437","resultStr":"{\"title\":\"BIOSYNTHESIS OF ASCORBIC ACID IN PLANTS: A Renaissance.\",\"authors\":\"N. Smirnoff, P. L. Conklin, F. Loewus\",\"doi\":\"10.1146/ANNUREV.ARPLANT.52.1.437\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The structure of the familiar antioxidant L-ascorbic acid (vitamin C) was described in 1933 yet remarkably, its biosynthesis in plants remained elusive until only recently. It became clear from radioisotopic labeling studies in the 1950s that plant ascorbic acid biosynthesis does not proceed in toto via a route similar to that in mammals. The description in 1996 of an Arabidopsis thaliana mutant deficient in ascorbic acid prompted renewed research effort in this area, and subsequently in 1998 a new pathway was discovered that is backed by strong biochemical and molecular genetic evidence. This pathway proceeds through the intermediates GDP-D-mannose, L-galactose, and L-galactono-1,4-lactone. Much research has focused on the properties of the terminal enzyme responsible for conversion of the aldonolactone to ascorbate, and on related enzymes in both mammals and fungi. Two of the plant biosynthetic genes have been studied at the molecular level and additional ascorbate-deficient A. thaliana mutants may hold the key to other proteins involved in plant ascorbate metabolism. An analysis of the biosynthesis of ascorbate and its analogues in algae and fungi as well as the study of alternative proposed pathways should broaden our understanding of ascorbate metabolism in plants. With a biosynthetic pathway in hand, research on areas such as the control of ascorbate biosynthesis and the physiological roles of ascorbate should progress rapidly.\",\"PeriodicalId\":80493,\"journal\":{\"name\":\"Annual review of plant physiology and plant molecular biology\",\"volume\":\"11 1\",\"pages\":\"437-467\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2001-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1146/ANNUREV.ARPLANT.52.1.437\",\"citationCount\":\"437\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Annual review of plant physiology and plant molecular biology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1146/ANNUREV.ARPLANT.52.1.437\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annual review of plant physiology and plant molecular biology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1146/ANNUREV.ARPLANT.52.1.437","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 437
摘要
人们所熟悉的抗氧化剂l -抗坏血酸(维生素C)的结构早在1933年就被描述出来了,但值得注意的是,直到最近,它在植物中的生物合成才得以实现。从20世纪50年代的放射性同位素标记研究中可以清楚地看出,植物抗坏血酸的生物合成并不是通过与哺乳动物相似的途径进行的。1996年对拟南芥抗坏血酸缺陷突变体的描述促使这一领域的研究重新开始,随后在1998年发现了一个新的途径,得到了强有力的生化和分子遗传学证据的支持。该途径通过中间产物gdp - d -甘露糖、l -半乳糖和l -半乳糖-1,4-内酯进行。许多研究都集中在负责将醛醛酸内酯转化为抗坏血酸的末端酶的特性,以及哺乳动物和真菌中的相关酶。两个植物生物合成基因已经在分子水平上进行了研究,其他抗坏血酸缺乏的拟南芥突变体可能具有参与植物抗坏血酸代谢的其他蛋白质的关键。对抗坏血酸及其类似物在藻类和真菌中的生物合成的分析,以及对替代途径的研究,将拓宽我们对植物抗坏血酸代谢的理解。随着生物合成途径的掌握,对抗坏血酸生物合成控制和抗坏血酸生理作用等领域的研究将迅速进展。
BIOSYNTHESIS OF ASCORBIC ACID IN PLANTS: A Renaissance.
The structure of the familiar antioxidant L-ascorbic acid (vitamin C) was described in 1933 yet remarkably, its biosynthesis in plants remained elusive until only recently. It became clear from radioisotopic labeling studies in the 1950s that plant ascorbic acid biosynthesis does not proceed in toto via a route similar to that in mammals. The description in 1996 of an Arabidopsis thaliana mutant deficient in ascorbic acid prompted renewed research effort in this area, and subsequently in 1998 a new pathway was discovered that is backed by strong biochemical and molecular genetic evidence. This pathway proceeds through the intermediates GDP-D-mannose, L-galactose, and L-galactono-1,4-lactone. Much research has focused on the properties of the terminal enzyme responsible for conversion of the aldonolactone to ascorbate, and on related enzymes in both mammals and fungi. Two of the plant biosynthetic genes have been studied at the molecular level and additional ascorbate-deficient A. thaliana mutants may hold the key to other proteins involved in plant ascorbate metabolism. An analysis of the biosynthesis of ascorbate and its analogues in algae and fungi as well as the study of alternative proposed pathways should broaden our understanding of ascorbate metabolism in plants. With a biosynthetic pathway in hand, research on areas such as the control of ascorbate biosynthesis and the physiological roles of ascorbate should progress rapidly.